Medicilon and Ray Everest: Driving a Production-Line Upgrade Through Strategic Partnership, Turning Capacity into Certainty

Preclinical CRO

On November 10, 2026, Medicilon and Ray Everest signed a strategic cooperation framework agreement on the “AI-Driven Upgrade of Automated Laboratory Production Lines for Life Sciences” in Shanghai. The two parties will work together to upgrade laboratory automation production lines across drug discovery and DMPK workflows, leveraging AI and automation technologies to improve unit throughput, […]

JSSX 2026

Medicilon Events

Nov. 16(Mon.) – 19 (Thu.), 2026. Venue: Tsukuba International Congress Center, Tsukuba, Japan.

Search Medicilon

Preclinical CRO

Medicilon and Ray Everest: Driving a Production-Line Upgrade Through Strategic Partnership, Turning Capacity into Certainty

Preclinical CRO

China’s First mRNA-Based In Vivo CAR-T Candidate! Medicilon Supports Regenelead RGL-208 IND Approval

Preclinical CRO

Medicilon and China Pharmaceutical University Forge Industry-University Research Collaboration on Novel Conjugate Therapeutics to Empower New Drug Innovation

Contact Medicilon

Name(Required)
Address(Required)